IMGN
Closed
Immunogen Inc
31.23
0.00 (0.00%)
Last Update: 13 Feb 2024 17:30:00
Yesterday: 31.23
Day's Range: 31.23 - 31.23
Send
sign up or login to leave a comment!
When Written:
3.805
ImmunoGen Inc is a biotechnology company that specializes in the development of targeted cancer therapies. The company was founded in 1981 and is headquartered in Waltham, Massachusetts. ImmunoGen's technology platform is based on the use of antibodies to deliver toxic payloads directly to cancer cells, while sparing healthy cells. The company has several products in development, including mirvetuximab soravtansine, which is being evaluated in clinical trials for the treatment of ovarian and other cancers. ImmunoGen also collaborates with other biotechnology and pharmaceutical companies to develop and commercialize its technology. The company's mission is to improve the lives of cancer patients through the development of innovative and effective therapies.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








